BABA
Alibaba Group Holding Ltd - ADR
-20.42%
$105.11 - $83.65
Feb 8th 2023 - Mar 22nd 2023
Mar, 14, 2023
$BABA options flow analysis suggests a bullish outlook for the stock.
Mar, 14, 2023
$BABA options flow analysis confirms the stock is ... See more
Divihomes is Now Live
A new search platform that matches you with the best home improvement service providers in your area.
Instant Search & Match with Top Contractors
Instant Communication with Local Contractors
Millions of Unbiased User Reviews
100% Free Quotes from Top-Notch Contractors
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$TGTX Options Flow 🤖 analysis suggests a bullish ... See more
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ... See more
No reviews available.
Mar, 14, 2023
$BABA options flow analysis suggests a bullish outlook for the stock.
Mar, 14, 2023
$BABA options flow analysis confirms the stock is poised for an uptick.
Mar, 7, 2023
I think this analysis holds alot of merit.
Oct, 20, 2022
$BABA the daily analysis is so funny to watch.
Oct, 17, 2022
$BABA #BABA 18 Oct 2022 https://www.tradingview.com/chart/BABA/zuqmEG0O-BABA-Analysis/ Price playing out nicely from my previous analysis.
Oct, 8, 2022
$BABA #BABA Good Technical Analysis This Week A 4.31% drop in price since my last analysis, bouncing off the bearish POI at 85.00 nicely.
Mar, 21, 2023
$TGTX Options Flow 🤖 analysis suggests a bullish outlook for the stock.
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ublituximab was associated with significant treatment benefit across multiple efficacy measures at Week 96 versus teriflunomide in participants who had not received prior DMT.